Early October listings climb to four

Health Minister Mark Butler has dropped another two early October PBS listings, announcing reimbursement for Arrotex's aZematop for eczema and a new form of Celltrion's biosimilar Omlyclo for severe asthma or hives.

To see the whole article please log in.

Christine Spiteri

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here